Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Scand J Rehabil Med ; 24(2): 75-81, 1992.
Article in English | MEDLINE | ID: mdl-1604265

ABSTRACT

The value of a diagnostic block (DB) of the tibial nerve in 17 hemiparetic patients with gait disturbances was investigated. The purpose of this study was to find instruments that help to select patients who will benefit from a long lasting peripheral nerve block. The manually elicited ankle clonus and its abolition after injection of a local anaesthetic appeared to be a useful clinical test for the efficacy of DB. Electrophysiological tests proved valuable when DB failed to produce clinical effects. With a substantial number of blocked nerve fibres walking velocity did not deteriorate. Transient disturbances in sensation can be regarded as unwanted side effects that might adversely affect the walking ability. From the different aspects of gait an improved heelcontact demonstrated the functional gain in patients with a dynamic equinus foot. To differentiate between a dynamic equinus foot and fixed contractures, we recommend the use of a fast acting local anaesthetic for diagnostic nerve blocks.


Subject(s)
Contracture/diagnosis , Foot/physiopathology , Gait/physiology , Hemiplegia/diagnosis , Nerve Block/methods , Tibial Nerve/drug effects , Adult , Aged , Bupivacaine/therapeutic use , Cerebrovascular Disorders/complications , Cerebrovascular Disorders/rehabilitation , Contracture/etiology , Electrophysiology , Female , Gait/drug effects , Hemiplegia/etiology , Hemiplegia/rehabilitation , Humans , Leg/innervation , Male , Middle Aged
2.
Epilepsia ; 16(1): 83-90, 1975 Mar.
Article in English | MEDLINE | ID: mdl-1122900

ABSTRACT

The effect od dipropylacetic acid (DPA; Depakine) on the bemegride-induced convulsive threshold was investigated in alert cats. Forty-five min after DPA 200 mg/kg, s.c., no significant effect was obtained; 5 min after the same dose iv., protection from bemegride-induced seizures was pronounced. DPA did not decrease focal discharges in sensorimotor cortex produced by topical cobalt, although spread of epileptogenic activity from the focus was inhibited. DPA antiepileptic protection tested by the same procedure was about the same as that given by phenobarbital and less than that given by diazepam.


Subject(s)
Anticonvulsants , Seizures/drug therapy , Valerates/therapeutic use , Animals , Anticonvulsants/administration & dosage , Bemegride , Cats , Cobalt , Injections, Intravenous , Injections, Subcutaneous , Seizures/chemically induced , Valerates/administration & dosage , Valerates/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...